GALECTIN THERAPEUTICS INC (GALT) › Total AssetsGALECTIN THERAPEUTICS INC (GALT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $6.30M2011: $6.61M2012: $9.56M2013: $10.71M2014: $29.68M2015: $26.41M2016: $15.79M2017: $4.16M2018: $9.01M2019: $48.47M2020: $29.60M2021: $41.83M2022: $21.29M2023: $28.20M2024: $17.50M2025: $19.53M$19.53M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$19.53M+11.6%2024$17.50M-38.0%2023$28.20M+32.5%2022$21.29M-49.1%2021$41.83M+41.3%2020$29.60M-38.9%2019$48.47M+438.2%2018$9.01M+116.4%2017$4.16M-73.7%2016$15.79M-40.2%2015$26.41M-11.0%2014$29.68M+177.0%2013$10.71M+12.0%2012$9.56M+44.6%2011$6.61M+5.0%2010$6.30M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share